跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOPRELOC-XL metoprolol succinate 23.75 mg modified release tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
TOPRELOC-XL metoprolol succinate 23.75 mg modified release tablet blister pack
Approved
STANDARD
TOPRELOC-XL metoprolol succinate 23.75 mg modified release tablet blister pack
Pharmacor Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
bc4365284fa2dd64
Company
Pharmacor Pty Ltd
Type
Standard
Approval Details
Approval Id
bc4365284fa2dd64
Product Name
TOPRELOC-XL metoprolol succinate 23.75 mg modified release tablet blister pack
Artg Id
356239
Artg Name
TOPRELOC-XL metoprolol succinate 23.75 mg modified release tablet blister pack
Sponsor
Pharmacor Pty Ltd
Company Detail Path
/organization/pharmacor-sa-pty-ltd
Artg Date
2022-03-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a115b250a33ec8133743f6926e38ad67.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/fe38aef6985f289284c1cac7ee6b65e5.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
bc4365284fa2dd64
Type
Standard
Back to TGA Approvals